TCL Archive The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.” By Cancer History Project August 13, 2004
TCL Archive Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal. By Cancer History Project August 13, 2004
TCL Archive Cooperative group chairman suggest changes to incentive system. By Cancer History Project August 13, 2004
TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. By Cancer History Project August 6, 2004
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. By Cancer History Project July 30, 2004
TCL Archive Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment By Cancer History Project July 30, 2004
TCL Archive Studies Test New Agents Offering Relief From Treatment-Related Side Effects By Cancer History Project July 30, 2004
TCL Archive Also in this 8-page issue: Rep. James Greenwood to become president of Biotechnology Industry Association. By Cancer History Project July 30, 2004
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
